Experimental Therapies for Ebola Virus Disease: What Have We Learned?

The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus

(2016) Laura K. McMullan et al.   ANTIVIRAL RESEARCH

Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days

(2016) Boubacar Diallo et al.   CLINICAL INFECTIOUS DISEASES

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

(2016) Lori E. Dodd et al.   JOURNAL OF INFECTIOUS DISEASES

Late Ebola virus relapse causing meningoencephalitis: a case report

(2016) Michael Jacobs et al.   LANCET

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

(2016) Travis K. Warren et al.   NATURE

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

(2016) Johan van Griensven et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Artesunate–Amodiaquine on Mortality Related to Ebola Virus Disease

(2016) Etienne Gignoux et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Management of Ebola Virus Disease in the United States and Europe

(2016) Timothy M. Uyeki et al.   NEW ENGLAND JOURNAL OF MEDICINE

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial

(2016) Jake Dunning et al.   PLOS MEDICINE

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

(2016) Daouda Sissoko et al.   PLOS MEDICINE

Experimental Treatment of Ebola Virus Disease with Brincidofovir

(2016) Jake Dunning et al.   PLoS One

Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick

(2015) Lilin Lai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus

(2015) Peter B. Jahrling et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

(2015) Ana Maria Henao-Restrepo et al.   LANCET

Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers

(2015) Michael Jacobs et al.   LANCET INFECTIOUS DISEASES

Persistence of Ebola Virus in Ocular Fluid during Convalescence

(2015) Jay B. Varkey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail

(2015) Jeffrey R. Kugelman et al.   Cell Reports

Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease

(2015) Ben S. Cooper et al.   PLOS MEDICINE

Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study

(2015) Oumar Faye et al.   PLOS MEDICINE

Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain

(2015) Marta Mora-Rillo et al.   Lancet Respiratory Medicine

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease

(2012) J. M. Dye et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA